We describe a biomarker-based approach to delivering chemotherapy that entails monitoring treatment changes in the circulating metabolome that reflect efficacy. In-vitro. multiple tumor cell lines were exposed to numerous chemotherapeutics. Supernatants were collected at baseline and 72 hours post treatment. https://ofidmkb678epd.blog2freedom.com/34909515/dissecting-the-contribution-of-single-nucleotide-polymorphisms-in-ccr9-and-ccl25-genomic-regions-to-the-celiac-disease-phenotype